Akhil Srivastava

1.8k citations
38 papers · 1.5k indexed · h-index 20
Topics
Extracellular vesicles in disease (17 papers)MicroRNA in disease regulation (13 papers)RNA Interference and Gene Delivery (10 papers)

In The Last Decade

Akhil Srivastava

34 papers receiving 1.4k citations

Peers

Akhil Srivastava
Comparison fields: 5 of 103
  • Molecular Biology 991
  • Cancer Research 513
  • Biomedical Engineering 285
  • Biomaterials 222
  • Plant Science 186
Replace Roghayyeh Baghban with:
Roghayyeh Baghban Iran
Gabriella Pagnan Italy
Antonella Bandiera Italy
Xi Liu China
Hyung Jun Ahn South Korea
Jiayi Qian China
Amir Syahir Malaysia
Ralph Graeser Germany
Xuting Zhang China
Akhil Srivastava relative to Roghayyeh Baghban Iran Roghayyeh Baghban's profile →
Citations per field
00.5×10×20×31×
Roghayyeh Baghban · 1×
Citations per year

Countries citing papers authored by Akhil Srivastava

Since Specialization
Citations

This map shows the geographic impact of Akhil Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhil Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhil Srivastava more than expected).

Fields of papers citing papers by Akhil Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akhil Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhil Srivastava. The network helps show where Akhil Srivastava may publish in the future.

Co-authorship network of co-authors of Akhil Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Akhil Srivastava. A scholar is included among the top collaborators of Akhil Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhil Srivastava. Akhil Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 7
5 9
6 0
7 20
8 6
9 12
10 37
11 30
12 14
13 86
14 55
15 225
16 157
17 75
18 24
19 82
20
SLOW RELEASE FERTILIZERS AND CITRUS : EMERGING FACTS
1

About Akhil Srivastava

Akhil Srivastava is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 38 papers that have together received 1.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (17 papers), MicroRNA in disease regulation (13 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Cancer Research (513 citations), Biomaterials (222 citations) and Molecular Biology (991 citations). Akhil Srivastava has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Rajagopal Ramesh, Anupama Munshi, Narsireddy Amreddy, Anish Babu, Ranganayaki Muralidharan, Janani Panneerselvam, Meghna Mehta, Yan D. Zhao, Rebaz Ahmed and Yangrae Cho. Their work appears in journals such as PLoS ONE, Cancer Research and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026